The influence of cryopreservation on a benzimidazole-resistant isolate of Haemonchus contortus conditioned for inhibited development.

Parasitol Res

Department of Veterinary Helminthology and Entomology, Faculty of Veterinary Medicine, State University Utrecht, The Netherlands.

Published: December 1988

Larvae of a fenbendazole (FBZ)-selected, benzimidazole-resistant strain of Haemonchus contortus were conditioned for inhibited development during 7 weeks at 15 degrees C. Sheep raised nearly worm-free were infected with nonfrozen larvae (L3). Larvae from the same batch were exsheathed and cryopreserved over liquid nitrogen for 1 year, and another group of sheep was infected with the same dose of these L3 larvae after thawing. Egg hatch assays for all sheep were done between 21 and 30 days post infection (p.i.). Fenbendazole susceptibility was tested by treating 50% of each group of sheep on day 30 p.i. Worm counts of all sheep were done on day 38 p.i. The exsheathment time of the designated frozen L3 larvae at 15 degrees C exceeded the usual time span at room temperature. Of the frozen L3 larvae, 60% was motile after thawing. The mean LC50 values (micrograms tiabendazole/ml) and the mean percentage of efficacy after FBZ treatment against total worm burden, adults and early L4 larvae of nonfrozen and frozen H. contortus were not significantly different. The mean percentages of take (infectivity) for nonfrozen and frozen doses were 35.3% and 5.9%, respectively (P less than 0.001). In nontreated sheep, the mean percentages of inhibition for nonfrozen and frozen doses were 91.9%, and 54.2%, respectively (P less than 0.01). The exsheathment time seems to be temperature-dependent. The induction of inhibited development of L3 larvae during 7 weeks was as effective as during 5 weeks at 15 degrees C.(ABSTRACT TRUNCATED AT 250 WORDS)

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF00531636DOI Listing

Publication Analysis

Top Keywords

inhibited development
12
nonfrozen frozen
12
haemonchus contortus
8
contortus conditioned
8
conditioned inhibited
8
larvae
8
development larvae
8
weeks degrees
8
group sheep
8
sheep day
8

Similar Publications

EZH2 inhibition induces pyroptosis via RHA-mediated S100A9 overexpression in myelodysplastic syndromes.

Exp Hematol Oncol

January 2025

Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

Myelodysplastic Syndromes (MDS) represent a group of heterogeneous myeloid clonal diseases derived from aberrant hematopoietic stem/progenitor cells. Enhancer of zeste homolog 2 (EZH2) is an important regulator in gene expression through methyltransferase-dependent or methyltransferase-independent mechanisms. Herein, we found EZH2 inhibition led to MDS cell pyroptosis through RNA Helicase A (RHA) down-regulation induced overexpression of S100A9, a key regulator of inflammasome activation and pyroptosis.

View Article and Find Full Text PDF

With the progress of atherosclerosis (AS), the arterial lumen stenosis and compact plaque structure, the thickening intima and the narrow gaps between endothelial cells significantly limit the penetration efficiency of nanoprobe to plaque, weakening the imaging sensitivity and therapy efficiency. Thus, in this study, a HO-NIR dual-mode nanomotor, Gd-doped mesoporous carbon nanoparticles/Pt with rapamycin (RAPA) loading and AntiCD36 modification (Gd-MCNs/Pt-RAPA-AC) was constructed. The asymmetric deposition of Pt on Gd-MCNs catalyzed HO at the inflammatory site to produce O, which could promote the self-motion of the nanomotor and ease inflammation microenvironment of AS plaque.

View Article and Find Full Text PDF

Hypertrophic scar (HS) is a common fibroproliferative disorders with no fully effective treatments. The conversion of fibroblasts to myofibroblasts is known to play a critical role in HS formation, making it essential to identify molecules that promote myofibroblast dedifferentiation and to elucidate their underlying mechanisms. In this study, we used comparative transcriptomics and single-cell sequencing to identify key molecules and pathways that mediate fibrosis and myofibroblast transdifferentiation.

View Article and Find Full Text PDF

Anti-inflammatory coupled anti-angiogenic airway stent effectively suppresses tracheal in-stents restenosis.

J Nanobiotechnology

January 2025

Department of Interventional Radiology, Key Laboratory of Interventional Radiology of Henan Province, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450001, China.

Excessive vascularization during tracheal in-stent restenosis (TISR) is a significant but frequently overlooked issue. We developed an anti-inflammatory coupled anti-angiogenic airway stent (PAGL) incorporating anlotinib hydrochloride and silver nanoparticles using advanced electrospinning technology. PAGL exhibited hydrophobic surface properties, exceptional mechanical strength, and appropriate drug-release kinetics.

View Article and Find Full Text PDF

Introduction: Bone marrow-derived mesenchymal stem cell-derived extracellular vesicles (BMSC-EVs) are widely used for therapeutic purposes in preclinical studies. However, their utility in treating diabetes-associated atherosclerosis remains largely unexplored. Here, we aimed to characterize BMSC-EV-mediated regulation of autophagy and macrophage polarization.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!